Control of placental infection by decidual NK cell secreted granulysin
Control of placental infection by decidual NK cell secreted granulysin
批准号:
9236206
负责人:
Judy Lieberman
金额:
$21.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-03-04 至 2018-02-28
关键词:
AllogenicAlpha CellAnti-Bacterial AgentsAntimicrobial EffectBacteriaCD8B1 geneCell Culture TechniquesCell LineCell secretionCellsCessation of lifeConflict (Psychology)Cytoplasmic GranulesCytotoxic T-LymphocytesDataDeciduaDependenceDoseEnzymesEquilibriumExocytosisExposure toFetal DistressFetal TissuesFetusFrequenciesGene ExpressionGoalsGranzymeHLA G antigenHerpesviridaeHumanHuman Parvovirus B19ImageImmuneImmune ToleranceImmune responseImmune systemImmunityInfectionInflammatoryKiller CellsKineticsLeadListeria monocytogenesMaternal HealthMaternal-Fetal ExchangeMediatingMembraneMicrobeModelingMolecularNatural Killer CellsParasitesPeptide HydrolasesPeptidesPlayPopulationPregnancyPregnancy ComplicationsPregnancy TrimestersPregnant UterusPremature LaborProcessProtein IsoformsProteinsResistanceRoleRubellaSideSiteSpecificityStreptococcus Group BStromal CellsSynapsesSyphilisTermination of pregnancyTissuesToxoplasma gondiiVascular remodelingVirusantimicrobial peptidebasecell killingcongenital anomalycytokinecytotoxicextracellularfetalfetus cellgranulysinimmunological synapsein uteroinsightkillingsmicrobialnovelpathogenperforinperipheral bloodplacental infectionpublic health relevancereceptor functiontherapy developmenttrophoblast
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): During pregnancy maternal immune cells need to establish immune tolerance of fetal and placental tissues, but also protect against infection. Decidual NK cells (dNK) are the largest maternal immune cell population at the maternal-fetal interface, where maternal and fetal tissues interact. This proposal will explore a novel and exciting mechanism by which dNK kill bacteria that infect fetal trophoblasts, but spare the fetal cells. Human dNKs highly express granulysin, an antimicrobial peptide that preferentially disrupts the membranes of microbes, but is less active against mammalian membranes. Granulysin is produced as an inactive 15 kDa pro-peptide that is processed in killer cell cytotoxic granules to a 9 kDa membranolytic peptide. Our preliminary data suggest that dNK cells have two intracellular pools of granulysin - one pool contains both the active and inactive forms of granulysin in cytotoxic granules together with perforin and granzymes, while the other pool contains only the inactive granulysin precursor. Preliminary data demonstrate that dNK constitutively secrete high levels of granulysin without the other cytolytic molecules. The culture
supernatants from dNKs, but not peripheral blood NK cells (pNK), kill extracellular L. monocytogenes as well as L. monocytogenes within fetal trophoblast cell lines without killing the trophoblast. Based on these preliminary data, we hypothesize that granulysin secretion kills intracellular pathogens in fetal cells without harming those cells. To investigate this hypothesis,
we propose to confirm our preliminary data showing that intracellular microbes are killed by dNK secretion of granulysin, independently of perforin and granzymes; determine whether bacteria or bacterial products or inflammatory cytokines upregulate granulysin expression and secretion; and understand how the trophoblast resists killing. We will also define whether granulysin secretion is constitutive or regulated and investigate whether dNKs respond differently to infected fetal extravillous trophoblasts (EVT, the most invasive fetal cells in the decidua) than t maternal decidual stromal cells (DSC). We will use imaging to determine whether dNK cells form an immune synapse with these infected cells, whether the type of synapse differs and whether the encounter triggers cytotoxic granule release. The models used will be 3 pathogens that cause complications during pregnancy - L. monocytogenes, Group B Streptococci (GBS) and Toxoplasma gondii.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tumor-targeted disruption of mismatch repair in microsatellite stable colorectal cancer
-
批准号:10578049
-
项目类别:
-
资助金额:$24.82万
-
财政年份:2022
-
负责人:Judy Lieberman
-
依托单位:
Mechanistic elucidation of inflammasome assembly and regulation. Supplement: Testing drugs that curtail inflammasome activation to suppress SARS-CoV-2 pathogenesis
-
批准号:10159600
-
项目类别:
-
资助金额:$26.5万
-
财政年份:2020
-
负责人:Judy Lieberman
-
依托单位:
Gasdermin E and pyroptosis in cancer
-
批准号:10375415
-
项目类别:
-
资助金额:$49.4万
-
财政年份:2020
-
负责人:Judy Lieberman
-
依托单位:
Endogenous ligand of the NK activating receptor NKp46
-
批准号:10116279
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2020
-
负责人:Judy Lieberman
-
依托单位:
Gasdermin E and pyroptosis in cancer
-
批准号:10583571
-
项目类别:
-
资助金额:$49.4万
-
财政年份:2020
-
负责人:Judy Lieberman
-
依托单位:
Decidual NK response to infection
-
批准号:10160812
-
项目类别:
-
资助金额:$83.58万
-
财政年份:2019
-
负责人:Judy Lieberman
-
依托单位:
Decidual NK response to infection
-
批准号:10462767
-
项目类别:
-
资助金额:$83.58万
-
财政年份:2019
-
负责人:Judy Lieberman
-
依托单位:
Decidual NK response to infection
-
批准号:10623205
-
项目类别:
-
资助金额:$83.58万
-
财政年份:2019
-
负责人:Judy Lieberman
-
依托单位:
Granulysin, Granzymes and Perforin in Bacterial Immune Defense
-
批准号:9222706
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2016
-
负责人:Judy Lieberman
-
依托单位:
Control of placental infection by decidual NK cell secreted granulysin
-
批准号:9092639
-
项目类别:
-
资助金额:$27.68万
-
财政年份:2016
-
负责人:Judy Lieberman
-
依托单位:
Aptamer-siRNA gene knockdown to treat epithelial triple negative breast cancer
-
批准号:9766827
-
项目类别:
-
资助金额:$39.27万
-
财政年份:2015
-
负责人:Judy Lieberman
-
依托单位:
Aptamer-siRNA gene knockdown to treat epithelial triple negative breast cancer
-
批准号:8884851
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2015
-
负责人:Judy Lieberman
-
依托单位:
IVIS Spectrum for In Vivo Imaging
-
批准号:8447806
-
项目类别:
-
资助金额:$41.8万
-
财政年份:2013
-
负责人:Judy Lieberman
-
依托单位:
Interferon Effects on HIV Transmission in Human Models
-
批准号:8852531
-
项目类别:
-
资助金额:$82.2万
-
财政年份:2012
-
负责人:Judy Lieberman
-
依托单位:
Interferon Effects on HIV Transmission in Human Models
-
批准号:8410956
-
项目类别:
-
资助金额:$11.92万
-
财政年份:2012
-
负责人:Judy Lieberman
-
依托单位:
Interferon Effects on HIV Transmission in Human Models
-
批准号:8659072
-
项目类别:
-
资助金额:$23.97万
-
财政年份:2012
-
负责人:Judy Lieberman
-
依托单位:
CD4 aptamer-siRNA chimeras to prevent HIV transmission
-
批准号:8473156
-
项目类别:
-
资助金额:$76.64万
-
财政年份:2012
-
负责人:Judy Lieberman
-
依托单位:
Interferon Effects on HIV Transmission in Human Models
-
批准号:8463121
-
项目类别:
-
资助金额:$82.2万
-
财政年份:2012
-
负责人:Judy Lieberman
-
依托单位:
Interferon Effects on HIV Transmission in Human Models
-
批准号:9064745
-
项目类别:
-
资助金额:$82.2万
-
财政年份:2012
-
负责人:Judy Lieberman
-
依托单位:
Interferon Effects on HIV Transmission in Human Models
-
批准号:8667986
-
项目类别:
-
资助金额:$82.2万
-
财政年份:2012
-
负责人:Judy Lieberman
-
依托单位:
海外基金